| Literature DB >> 31354320 |
Wenchang Yuan1,2, Jianhua Liu2,3, Youchao Zhan1, Li Wang2, Yanqiong Jiang1, Yanling Zhang1, Ning Sun1,4, Ning Hou1,5.
Abstract
BACKGROUND: Staphylococcus aureus is among the most common causes of health care- and community-associated infections worldwide. The distributions of different S. aureus clones change over time and also vary geographically. The purpose of this study was to determine the molecular type and antimicrobial resistance profiles of clinical S. aureus strains isolated in Urumqi, Northwestern China.Entities:
Keywords: Staphylococcus aureus; methicillin-resistant Staphylococcus aureus; methicillin-sensitive Staphylococcus aureus; molecular typing; pvl gene
Year: 2019 PMID: 31354320 PMCID: PMC6590632 DOI: 10.2147/IDR.S202906
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Molecular characteristics of 605 Staphylococcus aureus isolates from Urumqi, Northwestern China
| ST (No. of isolates,%) | SCC | No. of | ||
|---|---|---|---|---|
| MRSA (271) | ST239 (203,74.9%) | t030 (198), t233 (5) | III (203) | 0 |
| ST59 (34,12.5%) | t437 (32), t441 (1), t3523 (1) | IV (34) | 5 | |
| ST22 (6,2.2%) | t309 (6) | IV (6) | 0 | |
| ST398 (4,1.5%) | t034 (2), t693 (2) | V (4) | 1 | |
| ST72 (4,1.5%) | t324 (2), t664 (2) | IV (4) | 0 | |
| Other STs (20,7.4%) | t8918 (3), et al | II (2), III (11), IV (5), V (2) | 2 | |
| MSSA (334) | ST22 (99,29.6%) | t309 (87), t790 (2), t1977 (2), t5335 (1), t625 (1), t8221 (1), t8934 (1), t12442 (1), t12481 (1), t13828 (1), t15234 (1) | 80 | |
| ST121 (34,10.2%) | t435 (16), t284 (5), t1425 (3), t2091 (2), t159 (1), t162 (1), t1994 (1), t2086 (1), t2092 (1), t287 (1), t308 (1), t645 (1) | 18 | ||
| ST398 (33,9.9%) | t571 (12), t034 (8), t1451 (4), t011 (3), t2530 (1), t2582 (2), t3085 (1), t11483 (1), t12280 (1) | 6 | ||
| ST5 (28,8.4%) | t002 (9), t502 (7), t045 (2), t062 (2), t688 (2), t954 (2), t242 (1), t5353 (1), t548 (1), t895 (1) | 2 | ||
| ST7 (22,6.6%) | t796 (16), t091 (4), t2119 (1), t2883 (1) | 0 | ||
| ST188 (18,5.4%) | t189 (17), t1858 (1) | 0 | ||
| ST15 (14,4.2%) | t084 (9), t491 (2), t094 (1), t1034 (1), t793 (1) | 1 | ||
| Other STs (86,25.7%) | t078 (8), et al | 8 |
Note: *The percentage of isolates with the pvl gene was significantly greater for MSSA than MRSA (34.4% vs 3.0%, Student’s t-test: p<0.05).
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; ST, sequence type.
Typing results for 605 Staphylococcus aureus isolated from Urumqi, Northwestern China
| ST | Cases(%) | ||
|---|---|---|---|
| MRSA(271) | ST239 | 74.9% | <0.05 |
| ST59 | 12.5% | ||
| MSSA(334) | ST22 | 29.6% | <0.05 |
| ST121 | 10.2% | ||
| ST398 | 9.9% | ||
| ST5 | 8.4% | ||
| ST7 | 6.6% |
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; ST, sequence type.
Figure 1Prevalence of Staphylococcus aureus STs among different clinical specimens. (A) Proportions of the two predominant MRSA sequence types, ST239 and ST59, among all S. aureus isolates. (B) Proportions of the predominant MSSA sequence types, ST22, ST398, ST121, ST5, ST7, ST188, and ST15, among all S. aureus isolates. (C) Distribution of STs in abscess/wound specimens. (D) Distribution of STs in blood specimens. (E) Distribution of STs in sputum specimens. (F) Distribution of STs in specimens of other fluids. (C–F: black bars indicate MRSA and grey bars indicate MSSA.).
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; ST, sequence type.
Antibiotic profiles of 605 Staphylococcus aureus isolated from Urumqi, Northwestern China
| Agents | ST239 | ST59 | ST22 | ST121 | ST398 | ST5 | ST7 | MRSA | MSSA | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| n=45 | n=158 | n=34 | n=99 | n=34 | n=33 | n=28 | n=22 | n=271 | n=334 | MRSA VS.MSSA | |
| PEN | 100 | 100 | 100 | 97 | 88.2 | 81.8 | 96.4 | 100 | 100 | 91.6 | <0.05 |
| FOX | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | - |
| GEN | 100 | 100 | 0 | 0 | 0 | 15.2 | 25 | 68.2 | 78.6 | 9.3 | <0.05 |
| LEV | 100 | 100 | 0 | 0 | 0 | 6.1 | 7.1 | 0 | 79.3 | 1.2 | <0.05 |
| CIP | 100 | 100 | 0 | 0 | 0 | 9.1 | 14.3 | 0 | 79.7 | 3.9 | <0.05 |
| MXF | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 78.2 | 0 | <0.05 |
| RIF | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 77.5 | 0 | <0.05 |
| TET | 100 | 100 | 70.6 | 0 | 0 | 0 | 17.9 | 18.2 | 87.1 | 5.7 | <0.05 |
| ERY | 0 | 100 | 94.1 | 57.6 | 52.9 | 39.4 | 82.1 | 77.3 | 79.3 | 50.9 | <0.05 |
| CLI | 0 | 100 | 85.3 | 15.2 | 14.7 | 18.2 | 39.3 | 68.2 | 74.2 | 20.1 | <0.05 |
| SXT | 0 | 0 | 0 | 0 | 11.8 | 15.2 | 28.6 | 59.1 | 1.1 | 12.9 | <0.05 |
Abbreviations: PEN, penicillin; FOX, cefoxitin; GEN, gentamicin; LEV, levofloxacin; CIP, ciprofloxacin; MXF, moxifloxacin; RIF, rifampicin; TET, tetracycline; ERY, erythromycin; CLI, clindamycin; SXT, trimethoprim/sulfamethoxazole; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; ST, sequence type.